INS and pulmonary arterial hypertension: In addition, Metabolic reprogramming serves as a crucial driver in PAH, including hyper-glycolytic reprogramming, aberrant iron handling, insulin insensitivity, and defective sphingosine metabolism [5–8], however, whether and how mitochondrial dynamics regulates hypoxic PAH remain incompletely understood.